Saakshi Medtech & Panels LtdQ3 FY24Electrical Equipment

Saakshi Medtech & Panels Ltd

Q3 FY24 Earnings Call Analysis

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Revenue guidance

Category 2

→Expect revenue growth starting from H1 FY26, following deferred orders and operational normalization.
→New facility operational by April-May 2025, doubling existing capacity utilization and enabling growth.
→Anticipate around 20% revenue growth impact in the current financial year.
→Growth driven by diversified sectors: electrical panels, fabrication (radiators, railways), medical, and data centers.
→Orders from key customers (e.g., GE, Rolls-Royce, Siemens, L&T) expected to ramp up.
→Wind turbine generator (WTG) business to contribute significantly with 5.5 MW and 3.3 MW projects approved, projecting INR10-20 crores orders.
→Export sales showing 40% year-on-year growth, increasing export share to over 5%.
→Expansion into complete package solutions and fabrication expected to attract more business.
→New dedicated wind factory to focus on new developments, contributing to multiple-fold increase in GE-related revenue.

Category 3

→Revenue growth expected to resume from H1 FY26 after temporary setbacks in FY25.
→FY25 revenues projected to be under pressure, possibly lower than FY24's INR121 crores.
→Operating efficiencies and cost management efforts have been strong, supporting profitability.
→New facility (operational from Q2 FY25) to double capacity utilization, enabling future growth.
→Expansion into fabrication and electrical panels across sectors (wind turbines, data centers, defense) expected to boost revenues.
→New wind turbine products (5.5 MW and 3.3 MW prototypes) anticipated to contribute INR10-20 crores annually.
→Export sales have shown 40% growth year-over-year and now constitute over 5% of total sales, indicating incremental gains.
→Earnings per share declined in H1 FY25 but expected to improve with resumed growth.
→Margin improvements supported by reduction in finance cost (>74%) and strict cost control.
→Long-term growth seen as strong with product and customer diversification initiatives underway.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Saakshi Medtech & Panels Ltd and 1,400+ other companies.

→The transcript and presentation excerpts do not indicate any current or planned fundraising through debt or equity.
→Company emphasizes strengthening of the balance sheet with a 31.26% decrease in long-term borrowings, showing a focus on reducing debt.
→Capital expenditure is being funded internally, with INR407.84 lakh allocated to capital work in progress for infrastructure and manufacturing capacity.
→No mention or discussion of any new debt or equity issuance plans during the call or in the presentation.
→Management mentions prudent retained earnings management to increase shareholder funds, implying organic growth rather than reliance on external fundraising.

→The company has received a new significant order from Mahindra and Mahindra Finance (exact financial details restricted).
→There is an order worth approximately INR 2 crores pending execution for the defense business.
→A large order involving around 44 radiators and 44 DG sets for the data center business will start realizing from January 2025.
→Prototype orders for wind turbine generators (WTG) include 23 sets for 5.5 MW turbines (~INR 10 crores order book) and 2 prototype units for 3.3 MW turbines, with expected future orders around INR 20 crores.
→Some orders from key customers have been deferred due to operational delays but are not cancelled; these are expected to resume by mid-2025.
→The company is actively expanding its order book through new development projects, particularly in fabrication and electrical panels for diverse sectors like wind turbines, medical, defense, and data centers.

Yes

→Current capital work in progress (Capex) is INR 407.84 lakhs, focused on infrastructure and manufacturing capacity to meet future demand.
→Key ongoing capital project: New manufacturing facility expected to be fully operational by April-May 2025, aimed at replacing a rented facility and doubling existing production capacity.
→Strategic focus on expanding production with potential to add second and third shifts to increase capacity utilization.
→Investments in intangible assets amounting to INR 103.6 lakhs enhancing technology upgrades and product innovation.
→Plans to ramp up production capabilities to support growth in wind turbine control systems, fabrication, and electrical panels segments.
→Emphasis on strengthening balance sheet by reducing long-term borrowings by 31.26%, supporting financial stability for future investments.

How does Saakshi Medtech & Panels Ltd rank vs peers in Electrical Equipment?

Pro feature

1Saakshi Medtech & Panels Ltd

Rev 2Mar 3

See full Electrical Equipment sector rankings

Want more stocks like Saakshi Medtech & Panels Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.